DE60121999T2 - Verfahren zur herstellung von zusammensetzungen mit geringer salzkonzentration - Google Patents

Verfahren zur herstellung von zusammensetzungen mit geringer salzkonzentration Download PDF

Info

Publication number
DE60121999T2
DE60121999T2 DE60121999T DE60121999T DE60121999T2 DE 60121999 T2 DE60121999 T2 DE 60121999T2 DE 60121999 T DE60121999 T DE 60121999T DE 60121999 T DE60121999 T DE 60121999T DE 60121999 T2 DE60121999 T2 DE 60121999T2
Authority
DE
Germany
Prior art keywords
ligand
substance
liquid
ion
igg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60121999T
Other languages
German (de)
English (en)
Other versions
DE60121999D1 (de
Inventor
Makonnen Belew
Bo-Lennart Johansson
Jean-Luc Maloisel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Global Life Sciences Solutions USA LLC
Original Assignee
GE Healthcare Bio Sciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0004933A external-priority patent/SE0004933D0/xx
Application filed by GE Healthcare Bio Sciences Corp filed Critical GE Healthcare Bio Sciences Corp
Publication of DE60121999D1 publication Critical patent/DE60121999D1/de
Application granted granted Critical
Publication of DE60121999T2 publication Critical patent/DE60121999T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J41/00—Anion exchange; Use of material as anion exchangers; Treatment of material for improving the anion exchange properties
    • B01J41/20—Anion exchangers for chromatographic processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/04—Processes using organic exchangers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/26—Cation exchangers for chromatographic processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J41/00—Anion exchange; Use of material as anion exchangers; Treatment of material for improving the anion exchange properties
    • B01J41/04—Processes using organic exchangers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Seasonings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60121999T 2000-12-31 2001-12-19 Verfahren zur herstellung von zusammensetzungen mit geringer salzkonzentration Expired - Lifetime DE60121999T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0004933 2000-12-31
SE0004933A SE0004933D0 (sv) 2000-07-17 2000-12-31 A method for the manufacture of compositions containing low concentrations of salt
PCT/EP2001/015015 WO2002053288A2 (en) 2000-12-31 2001-12-19 A method for the manufacture of compositions containing low concentrations of salts

Publications (2)

Publication Number Publication Date
DE60121999D1 DE60121999D1 (de) 2006-09-14
DE60121999T2 true DE60121999T2 (de) 2007-07-26

Family

ID=20282508

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60121999T Expired - Lifetime DE60121999T2 (de) 2000-12-31 2001-12-19 Verfahren zur herstellung von zusammensetzungen mit geringer salzkonzentration

Country Status (9)

Country Link
US (1) US6852230B2 (enExample)
EP (1) EP1345694B1 (enExample)
JP (1) JP2004532182A (enExample)
AT (1) ATE334746T1 (enExample)
AU (1) AU2002235795A1 (enExample)
CA (1) CA2431662A1 (enExample)
DE (1) DE60121999T2 (enExample)
ES (1) ES2267840T3 (enExample)
WO (1) WO2002053288A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004018616D1 (de) * 2003-03-05 2009-02-05 Ge Healthcare Bio Sciences Ab Verfahren zur herstellung von multimodalen anionenaustauschliganden
SE0300612D0 (sv) * 2003-03-05 2003-03-05 Amersham Biosciences Ab A method of preparing ligands for hydrophobic interaction chromatography
SE0300624D0 (sv) * 2003-03-05 2003-03-05 Amersham Biosciences Ab A method of preparing affinity ligands
US7045059B2 (en) * 2003-07-28 2006-05-16 Sielc Technologies Corp Universal bonded phase material for chromatographic separation
KR101150050B1 (ko) * 2004-02-27 2012-07-05 지이 헬스케어 바이오-사이언시스 에이비 항체 정제 방법
SE0400501D0 (sv) * 2004-02-27 2004-02-27 Amersham Biosciences Ab Antibody purification
SE529259C2 (sv) * 2005-08-31 2007-06-12 Ge Healthcare Bio Sciences Ab Tillverkning av kromarografimatriser, en kromarografimatris, en vätskekromatografikolonn, prcess för att isolera målföreningar och användning av en kromarografimatris för vätskekromatografi
CN101678318B (zh) * 2007-05-25 2013-09-25 默克专利股份公司 用于阳离子交换色谱法的接枝共聚物
US20110155668A1 (en) * 2008-07-08 2011-06-30 Ge Healthcare Bio-Sciences Ab Separation medium for chromatography of various biomolecules
US20100029371A1 (en) * 2008-08-01 2010-02-04 Gennady Medvinsky Personal Game Services Commerce System (PGSCS)
US20120202976A1 (en) * 2009-10-12 2012-08-09 Ge Healthcare Bio-Sciences Ab Separation matrices
EP2509696B1 (en) 2009-12-07 2018-07-11 Fresenius Medical Care Holdings, Inc. Water purification cartridge using zirconium ion-exchange sorbents
IN2012DN06243A (enExample) * 2010-02-19 2015-09-25 Ge Healthcare Bio Sciences Ab
WO2014152488A2 (en) 2013-03-15 2014-09-25 Dreher Matthew R Imageable embolic microsphere
DE102016004432A1 (de) 2016-04-12 2017-10-12 Sartorius Stedim Biotech Gmbh Multimodales Adsorptionsmedium mit multimodalen Liganden, Verfahren zu dessen Herstellung und dessen Verwendung
CN109562352B (zh) 2016-08-01 2021-12-28 株式会社钟化 钙蛋白粒子的吸附材料以及吸附除去系统及其利用方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3234199A (en) * 1958-12-18 1966-02-08 Allen F Reid Ion exchange process for separating proteins
JPS5927830A (ja) * 1982-08-09 1984-02-14 Cosmo Co Ltd 抗腫瘍性糖蛋白質物質
US4599197A (en) * 1982-12-22 1986-07-08 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
DK114392D0 (da) * 1992-09-17 1992-09-17 Kem En Tec As Isolering af biomolekyler
US5652348A (en) 1994-09-23 1997-07-29 Massey University Chromatographic resins and methods for using same
GB9707696D0 (en) * 1997-04-16 1997-06-04 Agner Erik Improvements in or relating to chromatography
SE9802214D0 (sv) * 1998-06-18 1998-06-18 Amersham Pharm Biotech Ab Jonbytare och användning därav
US6310199B1 (en) * 1999-05-14 2001-10-30 Promega Corporation pH dependent ion exchange matrix and method of use in the isolation of nucleic acids
SE9904197D0 (sv) * 1999-11-22 1999-11-22 Amersham Pharm Biotech Ab A method for anion exchange adsorption on matrices carrying mixed mode ligands
SE0002688D0 (sv) * 2000-07-17 2000-07-17 Amersham Pharm Biotech Ab Adsorption method and ligands

Also Published As

Publication number Publication date
DE60121999D1 (de) 2006-09-14
ATE334746T1 (de) 2006-08-15
WO2002053288A3 (en) 2002-12-12
EP1345694B1 (en) 2006-08-02
WO2002053288A2 (en) 2002-07-11
ES2267840T3 (es) 2007-03-16
EP1345694A2 (en) 2003-09-24
AU2002235795A1 (en) 2002-07-16
CA2431662A1 (en) 2002-07-11
US6852230B2 (en) 2005-02-08
US20040050784A1 (en) 2004-03-18
JP2004532182A (ja) 2004-10-21

Similar Documents

Publication Publication Date Title
EP2152405B2 (de) Mischpfropfpolymere für die kationenaustauschchromatographie
DE69729182T2 (de) Prozess zur chromatographischen trennung von peptiden und nucleinsaure und neue ionentauschermatrix mit hoher affinität
DE69932944T2 (de) Chromatographisches verfahren und für das verfahren geeignetes säulenmaterial
DE60224685T2 (de) Herstellung von ionenaustauschermedien
EP2694527B1 (de) Verfahren zur trennung / reinigung von biomolekülen
US7008542B2 (en) Method for mixed mode adsorption
DE3851616T2 (de) Makroporöse Polymermembranen, ihre Herstellung und Verwendung zur Abtrennung von Polymere.
DE69836126T2 (de) Verfahren zur einbringung einer funktionalität
DE60307262T2 (de) Verfahren zur aufreinigung von albumin
AU2002235786A1 (en) A method for mixed mode adsorption and mixed mode adsorbents
JP2004516928A5 (enExample)
EP2310104A1 (de) Mischpfropfpolymere für die ionenaustauschchromatographie
EP1345694B1 (en) A method for the manufacture of compositions containing low concentrations of salts
EP3347125B1 (de) Adsorptionsmedium, verfahren zu dessen herstellung, sowie verwendung desselben zur aufreinigung von biomolekülen
JP2003531713A (ja) 陰イオン交換吸着方法およびチオエーテル陰イオン交換体
DE69433303T2 (de) Trennungsverfahren und synthetische polymere, die als trennungsmedien für dieses verfahren anwendbar sind
DE69011650T2 (de) Anionaustauscher.
DE69329676T2 (de) Passivierte und stabilisierte träger und methoden zu deren herstellung und verwendung
DE69007006T2 (de) Ligand enthaltendes Medium für chromatographische Trennung, Verfahren zur dessen Herstellung und dessen Verwendung zur Isolierung von synthetischen oder natürlichen Molekülen von einer Fluidmischung.
JP2004532182A5 (enExample)
DE602004013040T2 (de) Aufreinigung von immunglobulinen
EP1301279B1 (en) Adsorption method and ligands
WO1996014151A9 (de) Trennmaterialien und verfahren zu ihrer herstellung
DE4439444A1 (de) Trennmaterialien und Verfahren zu ihrer Herstellung
DE102013014242A1 (de) Hydrolytically Stable Ion-Exchange Stationary Phases and Uses Thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: HAMMONDS LLP, LONDON, GB